InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (45 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
45
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Finn Patrick John, President & Chief Operating Officer. Officer active across 1 company, notably Twist Bioscience Corp. In total, 104 reports have been recorded. Breakdown: 0 buy · 45 sells. Total volume traded: €13.7m. History available since 4 May 2021. The latest transaction was disclosed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Finn Patrick John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations104 total
4,046 shares@ US$139.066Common StockSEC:0001214659-26-010831:0
6,296 shares@ US$121.0070.0090% mcap2.7% of flowCommon StockSEC:0001214659-26-010645:6
33,354 shares@ US$115.8990.046% mcap13.7% of flowCommon StockSEC:0001214659-26-010645:1
10,420 shares@ US$116.82020.014% mcap4.3% of flowCommon StockSEC:0001214659-26-010645:2
23,355 shares@ US$67.850.019% mcap5.6% of flowCommon StockSEC:0001214659-26-010645:0
8,868 shares@ US$117.6970.012% mcap3.7% of flowCommon StockSEC:0001214659-26-010645:3
4,500 shares@ US$119.040.0063% mcap1.9% of flowCommon StockSEC:0001214659-26-010645:4
12,917 shares@ US$119.8580.018% mcap5.5% of flowCommon StockSEC:0001214659-26-010645:5
2,000 shares@ US$122.5810.0029% mcap0.9% of flowCommon StockSEC:0001214659-26-010645:7
2,888 shares@ US$85.32120.0040% mcap3.1% of flowCommon StockSEC:0001214659-26-009657:0
2,238 shares@ US$93.8930.0028% mcap2.7% of flowCommon StockSEC:0001214659-26-009065:0
2,321 shares@ US$60.7610.0018% mcap2.4% of flowCommon StockSEC:0001214659-26-005124:0
4,294 shares@ US$46.70982.6% of flowCommon StockSEC:0001214659-26-002445:0
18,205 shares@ US$23.335.4% of flowCommon StockSEC:0001214659-26-002179:0
1,000 shares@ US$23.330.3% of flowCommon StockSEC:0001214659-26-002041:0
2,705 shares@ US$46.5761.6% of flowCommon StockSEC:0001214659-26-001237:0
2,390 shares@ US$44.9081.4% of flowCommon StockSEC:0001214659-26-000873:0
3,279 shares@ US$8.820.4% of flowCommon StockSEC:0001214659-26-000508:0
1,776 shares@ US$26.50350.7% of flowCommon StockSEC:0001214659-25-017221:0
68,740 shares0Common StockSEC:0001214659-25-017000:0
2,755 shares@ US$32.07941.3% of flowCommon StockSEC:0001214659-25-015973:0
17,606 shares@ US$31.44438.4% of flowCommon StockSEC:0001214659-25-015766:0
79,785 shares0Common StockSEC:0001214659-25-015587:0
2,240 shares@ US$30.8751.1% of flowCommon StockSEC:0001214659-25-015366:0
23,747 shares@ US$32.18712.6% of flowCommon StockSEC:0001214659-25-014773:0
25 of 104 declarations
About Finn Patrick John
Finn Patrick John is President and Chief Operating Officer at Twist Bioscience Corp (XNAS). He has 93 filings in total, and across the 93 sampled filings between 2021-05-06 and 2026-04-27, the recorded activity consists only of sales for EUR 4870225, with the modal transaction nature listed as Retenue fiscale.
